Literature DB >> 7957786

Likelihood ratios: a real improvement for clinical decision making?

B Dujardin1, J Van den Ende, A Van Gompel, J P Unger, P Van der Stuyft.   

Abstract

The concept of likelihood ratio has been advocated for several years as one of the better means to evaluate diagnostic tests and as a practical and valuable tool in clinical decision making. In this paper we review the basic concepts underlying the evaluation of diagnostic tests and we explore the properties and usefulness of both positive and negative likelihood ratios compared with sensitivity and specificity. Particular attention is given to the use of likelihood ratios in the clinical setting. Likelihood ratios have three main advantages: they are intuitive, they simplify the predictive value calculation and the overall evaluation of sequential testing. Disadvantages are the non-linearity and the necessity to recalculate probabilities in odds. Although they summarize the information contained in sensitivity and specificity, these characteristics are still necessary for certain clinical decisions. Since likelihood ratios have been promoted among physicians and medical students, we discuss examples of inappropriate use and misunderstandings in the medical literature: the frequent omission of confidence intervals, the choice of cut-off points based on likelihood ratios for positive test results only and the confusion between likelihood ratios for ranges and those for cut-off points.

Mesh:

Year:  1994        PMID: 7957786     DOI: 10.1007/BF01717448

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  21 in total

Review 1.  Decision analysis in medicine.

Authors:  J G Thornton; R J Lilford; N Johnson
Journal:  BMJ       Date:  1992-04-25

2.  How sure is sure enough?

Authors:  S G Pauker; R I Kopelman
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

3.  Likelihood ratios. Another enhancement of sensitivity and specificity.

Authors:  J R Beck
Journal:  Arch Pathol Lab Med       Date:  1986-08       Impact factor: 5.534

4.  The likelihood ratio. An improved measure for reporting and evaluating diagnostic test results.

Authors:  K L Radack; G Rouan; J Hedges
Journal:  Arch Pathol Lab Med       Date:  1986-08       Impact factor: 5.534

Review 5.  Validation of screening procedures.

Authors:  A L Cochrane; W W Holland
Journal:  Br Med Bull       Date:  1971-01       Impact factor: 4.291

6.  Confidence intervals.

Authors:  C J Bulpitt
Journal:  Lancet       Date:  1987-02-28       Impact factor: 79.321

7.  The assessment of diagnostic tests. A survey of current medical research.

Authors:  S B Sheps; M T Schechter
Journal:  JAMA       Date:  1984-11-02       Impact factor: 56.272

8.  Precision of sensitivity estimations in diagnostic test evaluations. Power functions for comparisons of sensitivities of two tests.

Authors:  K Linnet
Journal:  Clin Chem       Date:  1985-04       Impact factor: 8.327

Review 9.  Carcinoembryonic antigen.

Authors:  R H Fletcher
Journal:  Ann Intern Med       Date:  1986-01       Impact factor: 25.391

10.  Re-evaluation of the diagnostic utility of serum total creatine kinase and creatine kinase-2 in myocardial infarction.

Authors:  F Y Leung; L V Galbraith; G Jablonsky; A R Henderson
Journal:  Clin Chem       Date:  1989-07       Impact factor: 8.327

View more
  19 in total

1.  Basic problems of serological laboratory diagnosis.

Authors:  W Fierz
Journal:  Mol Biotechnol       Date:  1999-12-01       Impact factor: 2.695

Review 2.  A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis.

Authors:  Joachim E Fischer; Lucas M Bachmann; Roman Jaeschke
Journal:  Intensive Care Med       Date:  2003-05-07       Impact factor: 17.440

3.  How useful are physical examination procedures? Understanding and applying likelihood ratios.

Authors:  Craig R Denegar; Missy Fraser
Journal:  J Athl Train       Date:  2006 Apr-Jun       Impact factor: 2.860

4.  Sample size for positive and negative predictive value in diagnostic research using case-control designs.

Authors:  David M Steinberg; Jason Fine; Rick Chappell
Journal:  Biostatistics       Date:  2008-06-12       Impact factor: 5.899

5.  Predicting long-term outcome after traumatic brain injury using repeated measurements of Glasgow Coma Scale and data mining methods.

Authors:  Hsueh-Yi Lu; Tzu-Chi Li; Yong-Kwang Tu; Jui-Chang Tsai; Hong-Shiee Lai; Lu-Ting Kuo
Journal:  J Med Syst       Date:  2015-01-31       Impact factor: 4.460

6.  Single-item screens identified patients with elevated levels of depressive and somatization symptoms in outpatient physical therapy.

Authors:  Dennis L Hart; Mark W Werneke; Steven Z George; Daniel Deutscher
Journal:  Qual Life Res       Date:  2011-06-07       Impact factor: 4.147

7.  Assessing the likelihood of obstructive sleep apnea: a comparison of nine screening questionnaires.

Authors:  Kuruswamy Thurai Prasad; Inderpaul Singh Sehgal; Ritesh Agarwal; Ashutosh Nath Aggarwal; Digambar Behera; Sahajal Dhooria
Journal:  Sleep Breath       Date:  2017-04-01       Impact factor: 2.816

8.  Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America.

Authors:  Cesar Muñoz; Beatriz L Gómez; Angela Tobón; Karen Arango; Angela Restrepo; Margarita M Correa; Carlos Muskus; Luz Elena Cano; Angel González
Journal:  Clin Vaccine Immunol       Date:  2009-11-25

9.  Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models.

Authors:  Hassan Roudgari; Zosia H Miedzybrodzka; Neva E Haites
Journal:  Fam Cancer       Date:  2007-12-21       Impact factor: 2.375

10.  Serum and pleural fluid procalcitonin in predicting bacterial infection in patients with parapneumonic effusion.

Authors:  Yang-Ching Ko; Wen-Pin Wu; Chi-Sen Hsu; Mong-Ping Dai; Chien-Chih Ou; Chih-Hsiung Kao
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.